Our strategy
Pharming’s vision is to become the leading global rare disease company of choice with a specific focus on transformative medicines in rare diseases. Our mission is to bring the unserved rare disease patients the solutions they need through our fully integrated and ongoing drug development and commercialization expertise. Pharming creates long-term value by leveraging its core strengths in clinical development and rare-disease drug commercialization.
To sustain longer-term additional growth, it is our objective to transform our pipeline from sole dependency on our rhC1INH technology platform, with the majority of revenues generated from one geography, to a company with multiple commercialized products in multiple geographies generating revenues across key markets. Additionally, Pharming aims to include a broader range of in-licensed or acquired technologies, as well as developing future indications for leniolisib.
Our Company Culture
At Pharming, we believe that everyone deserves the chance to have a good quality of life. As a leading biopharmaceutical company, we bring our patients the solutions that they need. Together, working as one team, communicating with one language and one story, we can achieve great things. That is the Pharming culture. It is a reflection of who we are and it inspires us to go the extra mile for our patients.
Our behaviors complement our core values and focus on self-development, teamwork, leading people and being results orientated. In our growing organization, it is important that employees feel connected and engaged. Our core values and behaviors enable our mission of bringing the unserved rare disease patients the solutions they need and create a clear pathway forward to meet our strategic goals and objectives.
